Cannara Biotech Inc (LOVE)

Currency in CAD
1.9500
+0.0100(+0.52%)
Delayed Data·
LOVE Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
LOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.92001.9500
52 wk Range
0.57001.9900
Key Statistics
Bid/Ask
1.93 / 1.95
Prev. Close
1.94
Open
1.92
Day's Range
1.92-1.95
52 wk Range
0.57-1.99
Volume
18.36K
Average Volume (3m)
88.85K
1-Year Change
212.9%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LOVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.0000
Upside
+53.85%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Cannara Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Cannara Biotech Inc Company Profile

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Cannara Biotech Inc Earnings Call Summary for Q3/2025

  • Revenue up 40% YoY to $27.3M; gross profit surged 110% to $12.1M; market share in Quebec rose to 12.6%
  • Adjusted EBITDA increased 170% YoY to $7.6M; net income up 25% QoQ to $4.1M; free cash flow soared 840% YoY to $11.7M
  • Maintaining 50,000 kg annual cultivation capacity; exploring new product categories and medical cannabis opportunities
  • CFO confident in becoming top Canadian producer; analyst price targets range from $24 to $38
  • Stock price rose 3.37% post-earnings; company faces risks of market saturation and regulatory changes
Last Updated: 28/07/2025, 17:04
Read Full Transcript

Compare LOVE to Peers and Sector

Metrics to compare
LOVE
Peers
Sector
Relationship
P/E Ratio
11.4x−4.4x12.2x
PEG Ratio
0.06−0.040.03
Price/Book
1.8x0.4x1.5x
Price / LTM Sales
1.7x1.7x0.9x
Upside (Analyst Target)
54.6%19.7%17.5%
Fair Value Upside
Unlock14.8%10.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.0000
(+53.85% Upside)

Earnings

Latest Release
Jul 28, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
27.33M / --
EPS Revisions
Last 90 days

LOVE Income Statement

People Also Watch

2.91
NURS
+5.82%
276.62
CLS
+1.27%
3.71
MCB
+1.09%

FAQ

What Stock Exchange Does Cannara Biotech Trade On?

Cannara Biotech is listed and trades on the TSX Venture Exchange stock exchange.

What Is the Stock Symbol for Cannara Biotech?

The stock symbol for Cannara Biotech is "LOVE."

What Is the Cannara Biotech Market Cap?

As of today, Cannara Biotech market cap is 178.29M.

What Is Cannara Biotech's Earnings Per Share (TTM)?

The Cannara Biotech EPS (TTM) is 0.17.

From a Technical Analysis Perspective, Is LOVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cannara Biotech Stock Split?

Cannara Biotech has split 1 times.

How Many Employees Does Cannara Biotech Have?

Cannara Biotech has 0 employees.

What is the current trading status of Cannara Biotech (LOVE)?

As of 07 Aug 2025, Cannara Biotech (LOVE) is trading at a price of 1.95, with a previous close of 1.94. The stock has fluctuated within a day range of 1.92 to 1.95, while its 52-week range spans from 0.57 to 1.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.